Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.22T | 2.06T | 1.71T | 1.02T | 728.68B | 1.97T |
Gross Profit | 385.53B | 413.67B | 281.80B | -54.47B | -298.29B | 363.17B |
EBITDA | 288.38B | 372.59B | 289.57B | 9.59B | -350.22B | 237.54B |
Net Income | 142.18B | 157.10B | 89.48B | -143.63B | -404.62B | 27.66B |
Balance Sheet | ||||||
Total Assets | 3.58T | 3.57T | 3.37T | 3.22T | 3.21T | 2.56T |
Cash, Cash Equivalents and Short-Term Investments | 1.22T | 1.26T | 1.18T | 950.99B | 965.72B | 238.65B |
Total Debt | 1.36T | 1.48T | 1.61T | 1.75T | 1.66T | 842.86B |
Total Liabilities | 2.43T | 2.52T | 2.50T | 2.42T | 2.20T | 1.49T |
Stockholders Equity | 1.14T | 1.04T | 862.42B | 797.25B | 1.01T | 1.06T |
Cash Flow | ||||||
Free Cash Flow | 152.65B | 180.15B | 332.93B | -209.78B | -427.15B | -221.19B |
Operating Cash Flow | 360.85B | 420.62B | 449.82B | -76.41B | -270.44B | 130.17B |
Investing Cash Flow | -481.27B | -399.52B | -202.03B | 230.02B | -595.44B | -230.22B |
Financing Cash Flow | -205.46B | -136.04B | -144.91B | 93.65B | 1.10T | 23.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $25.86B | 7.22 | 33.57% | ― | 5.31% | 35.95% | |
78 Outperform | $9.19B | 9.10 | 13.95% | 1.08% | 4.52% | -7.58% | |
78 Outperform | $32.38B | 8.79 | 27.52% | 1.21% | 4.91% | -27.21% | |
71 Outperform | $12.22B | 11.26 | 138.69% | 1.59% | 6.41% | 49.58% | |
68 Neutral | $18.33B | 38.19 | 5.63% | 2.24% | 3.26% | 27.77% | |
68 Neutral | £2.96B | 10.47 | 8.40% | 3.13% | 2.88% | -10.00% | |
64 Neutral | $7.44B | 13.02 | -21.27% | ― | 1.92% | 36.07% |